CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C22604 | BRD-K63487554 | BRD-K63487554 | -- | -- | -- | Details |
| C22605 | BRD-K63488275 | CS-2092524 | -- | -- | -- | Details |
| C22606 | BRD-K63490935 | homovanillic-acid | -- | -- | -- | Details |
| C22607 | BRD-K63493628 | BRD-K63493628 | -- | -- | -- | Details |
| C22608 | BRD-K63494246 | BRD-K63494246 | -- | -- | -- | Details |
| C22609 | BRD-K63500288 | BRD-K63500288 | -- | -- | -- | Details |
| C22610 | BRD-K63504496 | BRD-K63504496 | -- | -- | -- | Details |
| C22611 | BRD-K63504947 | semaxanib | FLT1; KDR; KIT; PDGFRB | VEGFR inhibitor | -- | Details |
| C22612 | BRD-K63511615 | SJB-AF-2 | -- | -- | -- | Details |
| C22613 | BRD-K63513868 | BRD-K63513868 | -- | -- | -- | Details |
| C22614 | BRD-K63516691 | T-0156 | PDE5A | Phosphodiesterase inhibitor | -- | Details |
| C22615 | BRD-K63521250 | BRD-K63521250 | -- | -- | -- | Details |
| C22616 | BRD-K63521663 | BRD-K63521663 | -- | -- | -- | Details |
| C22617 | BRD-K63523728 | BRD-K63523728 | -- | -- | -- | Details |
| C22618 | BRD-K63531989 | BRD-K63531989 | -- | -- | -- | Details |
| C22619 | BRD-K63532493 | BRD-K63532493 | -- | -- | -- | Details |
| C22620 | BRD-K63533170 | AM-630 | CNR1; CNR2 | Cannabinoid receptor antagonist | -- | Details |
| C22621 | BRD-K63539924 | BRD-K63539924 | -- | -- | -- | Details |
| C22622 | BRD-K63545954 | BRD-K63545954 | -- | -- | -- | Details |
| C22623 | BRD-K63547380 | BRD-K63547380 | -- | -- | -- | Details |
| C22624 | BRD-K63549648 | BRD-K63549648 | -- | -- | -- | Details |
| C22625 | BRD-K63550407 | erythromycin | MLNR | NFKB pathway inhibitor | -- | Details |
| C22626 | BRD-K63550534 | BRD-K63550534 | -- | -- | -- | Details |
| C22627 | BRD-K63559825 | BRD-K63559825 | -- | -- | -- | Details |
| C22628 | BRD-K63565086 | BRD-K63565086 | -- | -- | -- | Details |
| C22629 | BRD-K63568016 | BRD-K63568016 | -- | -- | -- | Details |
| C22630 | BRD-K63569039 | BRD-K63569039 | -- | -- | -- | Details |
| C22631 | BRD-K63573625 | BRD-K63573625 | -- | -- | -- | Details |
| C22632 | BRD-K63579322 | BRD-K63579322 | -- | -- | -- | Details |
| C22633 | BRD-K63583636 | BRD-K63583636 | -- | -- | -- | Details |
| C22634 | BRD-K63584084 | BRD-K63584084 | -- | -- | -- | Details |
| C22635 | BRD-K63585449 | BRD-K63585449 | -- | -- | -- | Details |
| C22636 | BRD-K63587518 | BRD-K63587518 | -- | -- | -- | Details |
| C22637 | BRD-K63587749 | BRD-K63587749 | -- | -- | -- | Details |
| C22638 | BRD-K63591202 | BRD-K63591202 | -- | -- | -- | Details |
| C22639 | BRD-K63596086 | BRD-K63596086 | -- | -- | -- | Details |
| C22640 | BRD-K63602071 | BRD-K63602071 | -- | -- | -- | Details |
| C22641 | BRD-K63603058 | BRD-K63603058 | -- | -- | -- | Details |
| C22642 | BRD-K63606607 | bufalin | ATP1A1 | ATPase inhibitor | -- | Details |
| C22643 | BRD-K63607326 | BRD-K63607326 | -- | -- | -- | Details |
| C22644 | BRD-K63614330 | BRD-K63614330 | -- | -- | -- | Details |
| C22645 | BRD-K63614890 | BRD-K63614890 | -- | -- | -- | Details |
| C22646 | BRD-K63616423 | BRD-K63616423 | -- | -- | -- | Details |
| C22647 | BRD-K63618292 | BRD-K63618292 | -- | -- | -- | Details |
| C22648 | BRD-K63624341 | BRD-K63624341 | -- | -- | -- | Details |
| C22649 | BRD-K63626200 | BRD-K63626200 | -- | -- | -- | Details |
| C22650 | BRD-K63628486 | BRD-K63628486 | -- | -- | -- | Details |
| C22651 | BRD-K63630713 | etacrynic-acid | SLC12A1 | Sodium/potassium/chloride transporter inhibitor | -- | Details |
| C22652 | BRD-K63631822 | BRD-K63631822 | -- | -- | -- | Details |
| C22653 | BRD-K63641886 | cefuroxime | -- | -- | -- | Details |
| C22654 | BRD-K63645840 | BRD-K63645840 | -- | -- | -- | Details |
| C22655 | BRD-K63651474 | BRD-K63651474 | -- | -- | -- | Details |
| C22656 | BRD-K63654001 | BRD-K63654001 | -- | -- | -- | Details |
| C22657 | BRD-K63662683 | BRD-K63662683 | -- | -- | -- | Details |
| C22658 | BRD-K63663384 | BRD-K63663384 | -- | -- | -- | Details |
| C22659 | BRD-K63665694 | BRD-K63665694 | -- | -- | -- | Details |
| C22660 | BRD-K63667213 | SA-1919584 | -- | -- | -- | Details |
| C22661 | BRD-K63668467 | BRD-K63668467 | -- | -- | -- | Details |
| C22662 | BRD-K63671514 | BRD-K63671514 | -- | -- | -- | Details |
| C22663 | BRD-K63675182 | triflupromazine | DRD2; HTR2B | Dopamine receptor antagonist | -- | Details |
| C22664 | BRD-K63682780 | cadmium | -- | -- | -- | Details |
| C22665 | BRD-K63684048 | BRD-K63684048 | -- | -- | -- | Details |
| C22666 | BRD-K63686806 | BRD-K63686806 | -- | -- | -- | Details |
| C22667 | BRD-K63697730 | BRD-K63697730 | -- | -- | -- | Details |
| C22668 | BRD-K63711119 | BRD-K63711119 | -- | -- | -- | Details |
| C22669 | BRD-K63711467 | BRD-K63711467 | -- | -- | -- | Details |
| C22670 | BRD-K63712590 | BRD-K63712590 | -- | -- | -- | Details |
| C22671 | BRD-K63712959 | temoporfin | -- | -- | -- | Details |
| C22672 | BRD-K63716333 | BRD-K63716333 | -- | -- | -- | Details |
| C22673 | BRD-K63716942 | BRD-K63716942 | -- | -- | -- | Details |
| C22674 | BRD-K63724542 | BRD-K63724542 | -- | -- | -- | Details |
| C22675 | BRD-K63730594 | BRD-K63730594 | -- | -- | -- | Details |
| C22676 | BRD-K63731274 | BRD-K63731274 | -- | -- | -- | Details |
| C22677 | BRD-K63733272 | BRD-K63733272 | -- | -- | -- | Details |
| C22678 | BRD-K63736853 | acipimox | -- | -- | -- | Details |
| C22679 | BRD-K63743653 | BRD-K63743653 | -- | -- | -- | Details |
| C22680 | BRD-K63750851 | BRD-K63750851 | -- | -- | mycophenolic-acid | Details |
| C22681 | BRD-K63754039 | BRD-K63754039 | -- | -- | -- | Details |
| C22682 | BRD-K63757709 | BRD-K63757709 | -- | -- | -- | Details |
| C22683 | BRD-K63757821 | BRD-K63757821 | -- | -- | -- | Details |
| C22684 | BRD-K63758740 | BRD-K63758740 | -- | -- | -- | Details |
| C22685 | BRD-K63761383 | BRD-K63761383 | -- | -- | -- | Details |
| C22686 | BRD-K63764020 | BRD-K63764020 | -- | -- | -- | Details |
| C22687 | BRD-K63770300 | BRD-K63770300 | -- | -- | -- | Details |
| C22688 | BRD-K63778487 | BRD-K63778487 | -- | -- | -- | Details |
| C22689 | BRD-K63779242 | BRD-K63779242 | -- | -- | -- | Details |
| C22690 | BRD-K63784565 | BRD-K63784565 | -- | -- | 10-hydroxycamptothecin | Details |
| C22691 | BRD-K63787803 | BRD-K63787803 | -- | -- | -- | Details |
| C22692 | BRD-K63792901 | BRD-K63792901 | -- | -- | arecaidine-but-2-ynyl-ester | Details |
| C22693 | BRD-K63798874 | BRD-K63798874 | -- | -- | -- | Details |
| C22694 | BRD-K63800697 | BRD-K63800697 | -- | -- | -- | Details |
| C22695 | BRD-K63801873 | BRD-K63801873 | -- | -- | -- | Details |
| C22696 | BRD-K63803358 | BRD-K63803358 | -- | -- | -- | Details |
| C22697 | BRD-K63806092 | sitaxentan | EDNRA | Endothelin receptor antagonist | -- | Details |
| C22698 | BRD-K63806140 | BRD-K63806140 | -- | -- | -- | Details |
| C22699 | BRD-K63807676 | BRD-K63807676 | -- | -- | -- | Details |
| C22700 | BRD-K63809385 | BRD-K63809385 | -- | -- | -- | Details |
| C22701 | BRD-K63809549 | BRD-K63809549 | -- | -- | -- | Details |
| C22702 | BRD-K63811860 | BRD-K63811860 | -- | -- | -- | Details |
| C22703 | BRD-K63813316 | BRD-K63813316 | -- | -- | -- | Details |